BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33798832)

  • 1. Telomere shortening correlates with disease severity in hemoglobin H disease patients.
    Panjawatanan P; Charoenkwan P; Tantiworawit A; Strogatz D; Perry KE; Tuntiwechapikul W
    Blood Cells Mol Dis; 2021 Jul; 89():102563. PubMed ID: 33798832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and molecular analysis in Thai patients with HbH disease.
    Laosombat V; Viprakasit V; Chotsampancharoen T; Wongchanchailert M; Khodchawan S; Chinchang W; Sattayasevana B
    Ann Hematol; 2009 Dec; 88(12):1185-92. PubMed ID: 19390853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Hb levels and degree of anemia in relation to genotype in 615 patients with hemoglobin H disease.
    Luo S; Chen X; Chen L; Zhong Q; Wang Q; Xu Z; Huang J; Yan T; Tang N
    Expert Rev Hematol; 2020 Sep; 13(9):1027-1033. PubMed ID: 32727230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and clinical features of hemoglobin H disease in Chinese patients.
    Chen FE; Ooi C; Ha SY; Cheung BM; Todd D; Liang R; Chan TK; Chan V
    N Engl J Med; 2000 Aug; 343(8):544-50. PubMed ID: 10954762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular analysis of haemoglobin H disease in Sardinia: haematological, obstetric and cardiac aspects in patients with different genotypes.
    Origa R; Sollaino MC; Giagu N; Barella S; Campus S; Mandas C; Bina P; Perseu L; Galanello R
    Br J Haematol; 2007 Jan; 136(2):326-32. PubMed ID: 17129226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region.
    Al-Riyami AZ; Daar S; Kindi SA; Madhani AA; Wali Y; Rawahi MA; Zadjali SA
    Hemoglobin; 2020 Jan; 44(1):20-26. PubMed ID: 32019385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinical features of Hb H disease in northern Thailand.
    Charoenkwan P; Taweephon R; Sae-Tung R; Thanarattanakorn P; Sanguansermsri T
    Hemoglobin; 2005; 29(2):133-40. PubMed ID: 15921165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nondeletional Hb Queens Park [α32(B13)Met→Lys]/Hb H (β4) disease.
    Sroymora S; Jindadamrongwech S; Butthep P; Chuncharunee S
    Hemoglobin; 2012; 36(3):293-8. PubMed ID: 22384838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hematological and Molecular Spectrum of α-Thalassemias in Turkey: The Hacettepe Experience.
    Ünal Ş; Gümrük F
    Turk J Haematol; 2015 Jun; 32(2):136-43. PubMed ID: 26316481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hb H Disease Diagnosed During Adolescent Pregnancy.
    Aksu T; Coşkun Ç; Kuşkonmaz B; Ünal Ş; Aytaç S; Gümrük F
    Hemoglobin; 2020 Mar; 44(2):137-138. PubMed ID: 32400222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral haemolysis, lipid peroxidation, iron status, and vitamin E in haemoglobin H syndromes in West Malaysia.
    George E; Wong HB; Jamaluddin M; Huisman TH
    Singapore Med J; 1993 Jun; 34(3):241-4. PubMed ID: 8266182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated telomere shortening in β-thalassemia/HbE patients.
    Chaichompoo P; Pattanapanyasat K; Winichagoon P; Fucharoen S; Svasti S
    Blood Cells Mol Dis; 2015 Aug; 55(2):173-9. PubMed ID: 25631622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte telomere length in patients with transfusion-dependent thalassemia.
    Nanthatanti N; Tantiworawit A; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L; Tuntiwechapikul W; Fanhchaksai K; Charoenkwan P; Kumfu S; Chattipakorn N
    BMC Med Genomics; 2020 Jun; 13(1):73. PubMed ID: 32487251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood screening for alpha-thalassemia and hemoglobin variants by isoelectric focusing in northern Thai neonates: correlation with genotypes and hematologic parameters.
    Charoenkwan P; Taweephol R; Sirichotiyakul S; Tantiprabha W; Sae-Tung R; Suanta S; Sakdasirisathaporn P; Sanguansermsri T
    Blood Cells Mol Dis; 2010 Jun; 45(1):53-7. PubMed ID: 20299254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha 2 codon 30 deletion (deltaGAG) causing non-deletional hemoglobin H disease in Guangxi province].
    Chen P; Li SQ; Wu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):435-9. PubMed ID: 15476164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematological Analysis in Thai Samples With Deletional and Nondeletional HbH Diseases.
    Pornprasert S; Salaeh NA; Tookjai M; Punyamung M; Pongpunyayuen P; Treesuwan K
    Lab Med; 2018 Mar; 49(2):154-159. PubMed ID: 29346671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of alpha-thalassemia.
    Vichinsky E
    Blood Rev; 2012 Apr; 26 Suppl 1():S31-4. PubMed ID: 22631041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity in clinical phenotype of nondeletional hemoglobin H disease with the same genetic defect.
    Li DZ
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):991. PubMed ID: 19935432
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel 31.2 kb α0 Deletion in a Palestinian Family with α-Thalassemia.
    Brieghel C; Birgens H; Frederiksen H; Hertz JM; Steenhof M; Petersen J
    Hemoglobin; 2015; 39(5):346-9. PubMed ID: 26114741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative levels of alpha 2-, alpha 1-, and zeta-mRNA in HB H patients with different deletional and nondeletional alpha-thalassemia determinants.
    Smetanina NS; Oner C; Baysal E; Oner R; Bozkurt G; Altay C; Gürgey A; Adekile AD; Gu LH; Huisman TH
    Biochim Biophys Acta; 1996 Aug; 1316(3):176-82. PubMed ID: 8781536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.